Will the FDA formally approve the Shield Blood Test by the end of 2024? | Binary | | | 7 months ago | |
What will be the adoption rate of the Shield Test in US medical facilities one year post FDA approval? | Categorical | | | 7 months ago | |
To how many countries will the Shield Test expand following FDA approval by the end of 2025? | Categorical | | | 7 months ago | |
How many competitors will introduce similar tests by the end of 2024? | Categorical | | | 7 months ago | |
Will Medicare announce reimbursement for the Shield Test by mid-2025? | Binary | | | 7 months ago | |
Guardant Health stock price up 10% post-FDA approval? | Binary | | | 7 months ago | |
Market adoption rate of Shield test in the first year | Categorical | | | 7 months ago | |
Shield test included in Medicare by mid-2025? | Binary | | | 7 months ago | |
FDA final approval of Shield test by end of 2024? | Binary | | | 7 months ago | |
Where will Guardant Health's colon cancer test be available by the end of 2026 following US FDA approval? | Categorical | | | 7 months ago | |
Will the FDA approve Guardant Health's colon cancer test by end of 2024? | Binary | | | 7 months ago | |
Will major insurance providers cover Guardant Health's colon cancer test within 6 months post-FDA approval? | Binary | | | 7 months ago | |
Will competitors introduce similar blood-based colon cancer tests by end of 2025? | Binary | | | 7 months ago | |
Will Guardant Health's stock price increase following FDA approval of the Shield Test? | Binary | | | 7 months ago | |
Annual revenue growth of Guardant Health post-Shield test launch | Categorical | | | 7 months ago | |
Number of competitors introducing similar tests by end of 2025 | Categorical | | | 7 months ago | |
How will Guardant Health's stock price react within 6 months post FDA approval of the colon cancer test? | Categorical | | | 7 months ago | |
Will major US health insurance providers cover Guardant Health's Shield blood test by May 31, 2025? | Binary | | | 5 months ago | |
Will Guardant Health's stock price increase by more than 30% by March 31, 2025? | Binary | | | 5 months ago | |
Will Guardant Health's Shield blood test achieve over 20% adoption rate in the US healthcare market by end of 2024? | Binary | | | 5 months ago | |
What will be the revenue generated by Guardant Health's Shield™ blood test by end of 2024? | Categorical | | | 5 months ago | |
Will Guardant Health's stock price increase by at least 20% by end of 2024? | Binary | | | 5 months ago | |
Will Guardant Health's stock price increase by 20% or more by the end of 2024? | Binary | | | 5 months ago | |
What will be the adoption rate of Guardant Health's Shield™ test among major hospitals and clinics by July 29, 2025? | Categorical | | | 5 months ago | |
Which Guardant Health test will receive FDA approval next by end of 2024? | Categorical | | | 5 months ago | |
Which non-invasive CRC screening test will have the largest market share in the US by June 30, 2025? | Categorical | | | 5 months ago | |
Which Guardant Health test will show positive results in clinical trials by November 30, 2024? | Categorical | | | 5 months ago | |
Will Medicare officially cover Guardant Health's Shield™ blood test by end of 2024? | Binary | | | 5 months ago | |
How many new competitors will enter the liquid biopsy market by end of 2024? | Categorical | | | 5 months ago | |
Will Guardant Health's Shield™ blood test be adopted by at least 20% of eligible adults by end of 2024? | Binary | | | 5 months ago | |
What will be the market share of Guardant Health's Shield™ blood test by end of 2024? | Categorical | | | 5 months ago | |
What will be Guardant Health's position in the colorectal cancer screening market by July 29, 2025? | Categorical | | | 5 months ago | |
How many Shield™ tests will Guardant Health sell in the first year after FDA approval? | Categorical | | | 5 months ago | |
Will Guardant Health's market share increase by July 29, 2025 due to Shield™ test approval? | Binary | | | 5 months ago | |
Will Guardant Health's Shield™ test receive Medicare reimbursement approval by the end of 2024? | Binary | | | 5 months ago | |
What will be the market adoption rate of Guardant Health's colon cancer test by the end of 2025? | Categorical | | | 7 months ago | |
